Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C.
about
Markedly lower follow-up rate after liver biopsy in patients with non-alcoholic fatty liver diseases than those with viral hepatitis in Japan.Introduction to therapy of hepatitis C.Delayed development of hepatocellular carcinoma during long-term follow-up after eradication of hepatitis C virus by interferon therapy.Hepatocellular cancer in HIV-infected individuals: tomorrow's problem?Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART eraChemoprevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis.Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy.Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye.Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection.Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis C after the eradication of hepatitis C virus: A multicenter study from Japan.MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy.Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C.Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C.Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes.Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection.Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.A randomized study of alpha-interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders.Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy.Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy.Analysis of hepatocellular carcinoma tumor growth detected in sustained responders to interferon in patients with chronic hepatitis C.Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.
P2860
Q34015290-E220363C-FE78-4BC2-BE94-E9EB8F3D90E1Q34984075-20487FBE-C556-4D02-ACC3-C43D7EA2775CQ36496830-761666FA-FF8C-4F33-A3BC-4746633AB456Q36668229-896EF6CF-95AF-45B1-8E24-6FCD492F85E5Q37113540-8DA09D82-6E95-409D-8EAD-FC343E3BDA6EQ37266324-9DFD7879-9F61-4690-ADB1-D4F49BC440E3Q38232812-81DC60CE-59FE-4D0A-AA2A-E51436A37756Q38522791-63839D2A-11F9-47F3-8387-85FF999CC838Q39039478-7C574E68-F047-4D10-96D6-C2002FCA1143Q40934730-1940D863-3FE2-419F-A116-73C65C99778CQ41412266-26A9E07B-69F9-43E3-92E1-D8B753236FFEQ41535486-446BC031-483E-4679-B200-E45B5E93A0F6Q42202049-99EC8BB1-9E59-4E44-9880-D9AEBF8AE033Q42250363-1637FD6B-EFE0-4E33-BC45-4F96198C3BC7Q42947251-F02B90C0-6E63-446C-9EBC-C9586B42B8AAQ42994249-DB7C582C-F2FB-435D-BC8D-7099D3F73C4BQ43037458-2511C803-23FE-48ED-B72F-4D4E247B28A5Q45164435-C47DC612-D4AE-4B2F-9F0B-B4F2638B94C9Q45368558-770ED23A-B10F-41B3-831B-372DFB8222DAQ50686838-DE68A4F9-4E0E-49A7-8C3C-4917AD5B8088Q55065395-C9BC8175-6D92-4673-8846-2B5E9B67F6DF
P2860
Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Long-term follow-up of sustain ...... ents with chronic hepatitis C.
@en
Long-term follow-up of sustain ...... ents with chronic hepatitis C.
@nl
type
label
Long-term follow-up of sustain ...... ents with chronic hepatitis C.
@en
Long-term follow-up of sustain ...... ents with chronic hepatitis C.
@nl
prefLabel
Long-term follow-up of sustain ...... ents with chronic hepatitis C.
@en
Long-term follow-up of sustain ...... ents with chronic hepatitis C.
@nl
P2093
P2860
P1476
Long-term follow-up of sustain ...... ents with chronic hepatitis C.
@en
P2093
D Nishimura
T Hayakawa
P2860
P304
P356
10.1046/J.1365-2893.2000.00241.X
P50
P577
2000-11-01T00:00:00Z